 Home > Biochemistry News > Biotechnology News > The 2nd China Wuhan Optics Valley Biology Annual Conference 2022 ended successfully!

The 2nd China Wuhan Optics Valley Biology Annual Conference 2022 ended successfully!

 Last Update: 2022-08-30
 Source: Internet
 Author: User

Tags

diamond making process

eyebrows makeup products

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[2022 2nd China Wuhan Optics Valley Biological Academic Conference and Biopharmaceutical Quality Analysis Technology Forum] came to a successful conclusion!

Some speakers, in no particular order

Protein Analysis Based on Ionic Liquid Extraction
Zhang Yukui Academician of Chinese Academy of Sciences

Application of Continuous Antibody Process in GMP Production

Zhang Xichen Senior Vice President of Hangzhou Yi'an Jishi Biological Production

Quality Management in Construction Projects of Manufacturing Plants of Pharmaceutical Enterprises
Luo Zhigang Senior Vice President and Quality Manager of Dingkang (Wuhan) Biological Co.
, Ltd

Accelerating the R&D and Industrialization of Cell Therapy Products
Zhang Yu Deputy General Manager and Chief Scientific Officer of Zhongyuan Xiehe Cell Genetic Engineering Co.
, Ltd.

Development of Biological Activity Analysis Methods for Antibody Drugs
Luo Fengyan R&D Director, Wuhan Youzhiyou Biopharmaceutical Co.
, Ltd.

Characterization of high-resolution mass spectrometry in complex biological products
Tang Kai SCIEX China, Biopharmaceutical Market Development Manager

Taking broad-spectrum HPV vaccine as an example - the development and thinking ofthe
vaccineindustry

Detection Strategies of Host Protein Impurities in Antibody Drug Purification Process
Li Muchen Director of Process Department of Wuxi WuXi Biotechnology Co.
, Ltd.

Characterization and Quality Control Solutions of Gene Therapy Products
Nan Yao Market Development Manager, Life Sciences Marketing Department, Danaher

Research and development of process-specific CHO cell host protein residue kit
Li Maohua Deputy General Manager of Jingtiancheng Biotechnology (Beijing) Co.
, Ltd.

Elements of Quality Management System Construction for Cell Therapy Product Production
Xie Xiaoming Senior Consultant of Compliance Consulting Service of AUSTAR Group

Re-understanding the key quality attributes of CAR-T cell products
Qi Feifei Co-founder & CTO of Beijing Yimiao Shenzhou Pharmaceutical Technology Co.
, Ltd.

Development and application of new technologies for single-cell biomacromolecules spatial omics
Cao Gang, Professor, Huazhong Agricultural University

Problems and Countermeasures in R&D and Registration of Gene and Cell Therapy Products
Liu Shuangsheng, Quality President of Yiming Cell Biotechnology Co.
, Ltd.

Suggestions for Standardizing Biopharmaceutical Preclinical Research
Fang Zhizheng, CQO of Wuhan Binhui Biotechnology Co.
, Ltd.

Exhibitors communicate with users

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.